Mindfulness meditation for pregnant women with preeclampsia
The Effect of Mindfulness Breath Awareness Meditation on Health Profile, Vital Signs, and Fetal Heart Rate in Pregnant Women Diagnosed With Preeclampsia
This study is testing if mindfulness meditation can improve the health and well-being of pregnant women with preeclampsia and their babies.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 19 Years to 49 Years |
| Sex | Female |
| Sponsor | University of Gaziantep Academic / other |
| Locations | 1 site (Şanlıurfa, Eyalet/Yerleşke) |
| Trial ID | NCT06065709 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of mindfulness breath awareness meditation (MBAM) on the health profile, vital signs, and fetal heart rate of pregnant women diagnosed with preeclampsia. A total of 66 women will be randomly assigned to either an experimental group receiving MBAM or a control group receiving standard care. The meditation sessions will occur every eight hours for 72 hours, with each session lasting 20 minutes. Data will be collected through health profiles and vital signs assessments before and during the intervention.
Who should consider this trial
Good fit: Ideal candidates are pregnant women aged 19 to 49 years, diagnosed with preeclampsia, and at least 20 weeks gestation.
Not a fit: Patients who do not meet the inclusion criteria or choose to withdraw from the study may not benefit.
Why it matters
Potential benefit: If successful, this approach could improve health outcomes for pregnant women with preeclampsia and their fetuses.
How similar studies have performed: While mindfulness interventions have shown promise in various health contexts, this specific application in preeclampsia is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * pregnant women who is admitted to the Perinatology Service of the hospital with the diagnosis of preeclampsia, * who is 19 to 49 years old, * who is 20 and over weeks of gestation, * who followes by at least three days of hospitalization in the ward. Exclusion Criteria: * Pregnant women who do not meet the inclusion criteria and who voluntarily withdraw at any stage after inclusion will be excluded from the study.
Where this trial is running
Şanlıurfa, Eyalet/Yerleşke
- Şanlıurfa training and research hospital — Şanlıurfa, Eyalet/Yerleşke, Turkey (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.